×

ScripsAmerica's PIMD International Receives DEA License to Distribute Class 2 Through 5 Pharmaceutical Formularies

TYSONS CORNER, Va., April 22, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that PIMD International, LLC has recently received a license to receive, store and ship Schedule 2 through Schedule 5 formulary pharmaceuticals in Florida and Pennsylvania.

PIMD International's new headquarters, located in Doral, Florida, passed the inspection process necessary to receive the licenses for products that are designated as Schedule 2,3,4 and 5 by the DEA. The Company expects PIMD's revenue to grow with the addition of these new formularies and is in the process of expanding its market reach by applying for licensing in additional states.

PIMD International serves as a pharmaceutical wholesaler to pharmacies, hospitals, and physician's offices in the US and provides ScripsAmerica's customers with access to specific medications for its end users. PIMD also sells medical supplies in all healthcare settings and online at www.pimdintl.com.

"We are very excited to receive these pharmaceutical dispersement licenses by the DEA as they expand PIMD's ability to service independent pharmacies in new areas with additional products. We expect these new licenses to generate rapid growth in our prescription revenues and expect to experience growth on all fronts in 2014 which includes sales from our medical supply website as well," stated PIMD International's Founder, Vanessa Gonzalez, PharmD.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: 888-959-7095Source:ScripsAmerica, Inc.